Kimberly Stegmaier has been named as Pediatric Oncology Chair at Dana-Farber Cancer Institute

Career Updates
Feb 23, 2025 12:27 pm
Dana-Farber/X Kimberly Stegmaier has been named as Pediatric Oncology Chair at Dana-Farber Cancer Institute
Dana-Farber Cancer Institute Shared a Post On LinkedIn “Kimberly Stegmaier, MD, has been named as Pediatric Oncology Chair. She will also serve as Associate Chief of Division of Hematology/Oncology at Boston Children’s Hospital. Please join us in congratulating her on this achievement. Read more.”
Benjamin Ebert, President and CEO of Dana-Farber Cancer Institute, shared this post, adding: “Congratulations to Kimberly Stegmaier, MD, on being named the next Chair of Pediatric Oncology at Dana-Farber Cancer Institute and Associate Chief of the Division of Hematology/Oncology at Boston Children’s Hospital. I am proud to know and to have worked alongside Kim for many years. She is deeply devoted to our young patients and their families and to the quest for new therapies. I am excited for her to lead our Department of Pediatric Oncology and to build on its strong foundation for years to come.”
More posts featuring Dana-Farber Cancer Institute and Benjamin Ebert.
Stay Informed
Subscribe to OncoDaily Newsletter
Don't miss the latest news in oncology: stay up to date with daily picks from OncoDaily.
Subscribe
Career Updates
Benjamin Ebert cancer
Dana-Farber Cancer Institute
Kimberly Stegmaier
OncoDaily
Oncology